Continuous Blood Pressure Monitoring from a Wearable Signal - No ECG Hardware Required

This technology is a software framework that uses photoplethysmography (PPG) signals — the same optical signals captured by consumer wearables — to synthetically generate ECG-equivalent outputs and derive continuous blood pressure readings. By eliminating the need for dedicated ECG hardware, it enables clinical-grade blood pressure monitoring in everyday wearable form factors.

Description

The framework employs a diffusion-based generative model that learns to transform PPG waveforms — easily captured via a fingertip or wrist-worn optical sensor — into high-fidelity synthetic ECG signals. Central to the approach is a QRS adaptive search module, which targets the most diagnostically significant portion of the cardiac cycle during signal generation, selectively controlling noise to improve output fidelity. Complementary scale and frequency alignment modules then ensure the synthesized ECG matches real ECG characteristics in both amplitude and timing. Rather than treating ECG generation and blood pressure estimation as separate tasks, the system integrates blood pressure prediction directly into the generative model's training process. This end-to-end design means the model is jointly optimized for both signal quality and clinical accuracy, yielding blood pressure estimates that rival those achievable with dedicated ECG equipment — from a sensor already present in most modern wearables.

Applications

- Consumer wearables (smartwatches, fitness bands) seeking to add continuous, cuff-free blood pressure monitoring as a differentiating health feature.
- Remote patient monitoring platforms managing hypertension, cardiovascular disease, or post-surgical recovery outside clinical settings.
- Digital health and telehealth companies building software-driven cardiac monitoring tools compatible with existing PPG-equipped devices.
- Clinical research and pharmaceutical trial infrastructure requiring continuous, non-invasive hemodynamic data collection at scale.
- Medical device manufacturers developing next-generation vital-sign monitoring systems for hospital, home, or point-of-care environments.

Advantages

- Achieves ECG-level blood pressure monitoring accuracy using only PPG sensors already embedded in consumer wearables, eliminating the need for additional hardware.
- Enables continuous, ambulatory blood pressure tracking without cuffs or clinical-grade electrode arrays, lowering barriers to patient compliance and long-term monitoring.
- Novel QRS adaptive search module improves the quality of generated cardiac signals, directly translating to more accurate blood pressure readings.
- End-to-end training architecture jointly optimizes signal synthesis and blood pressure estimation, reducing error accumulation common in multi-stage pipelines.
- Software-only solution deployable on existing wearable and mobile hardware platforms, enabling low-cost adoption and scalable integration.

Invention Readiness

The technology has been implemented as working software and validated through experimental evaluation. The current prototype demonstrates the feasibility of the end-to-end generative pipeline and its blood pressure estimation performance. Further development would include validation on broader and more diverse subject populations, real-world wearable integration testing, and regulatory pathway assessment for clinical use contexts.

IP Status

Related Publication(s)

Ji, H., & Zhou, P. (2024). Advancing PPG-Based Continuous Blood Pressure Monitoring from a Generative Perspective. Proceedings of the 22nd ACM Conference on Embedded Networked Sensor Systems, 661–674. https://doi.org/10.1145/3666025.3699365